Lily Device trial to reduce hair loss during chemo
Part of Cancer, Skin clinical trials.
This trial tests a device called Lily that you wear during and after chemotherapy to help prevent hair loss. It's for people with breast cancer who are about to start specific types of chemo.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older with stage 1, 2, or 3 breast cancer and haven't started chemo yet.
- You will receive one of the listed chemo regimens, like doxorubicin and cyclophosphamide, or paclitaxel, or docetaxel.
- Your treatment plan includes at least 4 cycles of chemo and will be completed within 12 months.
- You can wear the Lily device during chemo and for 2 to 4 hours after each session.
- You do not have any hair loss or scalp conditions, and you have not used scalp cooling devices recently.
- You are not pregnant and do not have other serious medical issues that could interfere.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether photobiomodulation (a specific light therapy) can prevent or reduce hair loss caused by chemotherapy. It may help you keep more hair or grow hair back sooner while you’re getting treatment.
This trial tests whether minoxidil (a hair-regrowth medication) alone or combined with red-light therapy can help hair grow back after breast cancer chemotherapy. The goal is to help patients recover from chemotherapy-induced hair loss.
This Phase 2 trial tests whether using a scalp-cooling device during chemotherapy can help prevent or lessen hair loss in people with metastatic invasive breast cancer. You would need to be starting a specific chemotherapy plan and be willing to begin scalp cooling with your first treatment.
This trial tests a treatment called DA-007 to see if it can prevent hair loss caused by chemotherapy in people with early-stage breast cancer. If you are about to start chemotherapy with taxane or anthracycline drugs, this study might help you keep your hair.
This trial tests a cooling cap (DA-020) to see if it can prevent hair loss during breast cancer chemotherapy. It may help you keep more of your hair while getting treatment.
This study tests whether a portable cooling cap system can reduce hair loss for women with breast cancer who are planning certain chemotherapy treatments. It may help you keep more of your hair while you receive chemotherapy.
Hear when a new Chemotherapy Induced Alopecia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.